MicroRNA-192 Suppresses Cell Proliferation and Induces Apoptosis in Human Rheumatoid Arthritis Fibroblast-like Synoviocytes by Downregulating Caveolin 1
Overview
Authors
Affiliations
Fibroblast-like synoviocytes (FLSs) play an important role in the pathogenesis of rheumatoid arthritis (RA). This study was conducted to explore the role of microRNA (miR)-192 in the regulation of the biology of RA-FLSs. The expression of miR-192 in RA and healthy synovial tissues was measured. The effects of overexpression of miR-192 on RA-FLS proliferation and apoptosis were investigated. Luciferase reporter assay and Western blot analysis were performed to identify direct target genes of miR-192. RA synovial tissues had significantly lower levels of miR-192 than healthy controls (P = 0.004). Moreover, miR-192 levels were 2.9-fold lower in RA-FLSs relative to normal human FLSs (P < 0.05). Ectopic expression of miR-192 significantly inhibited the proliferation and caused a cell cycle arrest at the G0/G1 phase in RA-FLSs. Moreover, miR-192 overexpression triggered apoptosis, which was accompanied by an increase in caspase-3 activity and Bax/Bcl-2 ratio. Caveolin 1 (CAV1) was identified to be a direct target of miR-192. Overexpression of miR-192 led to a reduction of endogenous CAV1 in RA-FLSs. Silencing of CAV1 significantly decreased cell proliferation and promoted apoptosis in RA-FLSs. Rescue experiments with a miR-192-resistant variant of CAV1 showed that enforced expression of CAV1 restored cell proliferation and attenuated apoptosis in miR-192-overexpressing RA-FLSs. In conclusion, miR-192 is downregulated in RA synovial tissues and restoration of its expression elicits growth-suppressive effects on RA-FLSs by targeting CAV1. The miR-192/CAV1 pathway may represent a novel target for prevention and treatment of RA.
MicroRNAs as Key Regulators in RA and SLE: Insights into Biological Functions.
Li X, Zhao C, Wei H, Li S, Tang J, Zhu Y Curr Pharm Des. 2024; 30(22):1746-1761.
PMID: 38798216 DOI: 10.2174/0113816128303695240512141729.
Giriyappagoudar M, Vastrad B, Horakeri R, Vastrad C Biomedicines. 2023; 11(12).
PMID: 38137330 PMC: 10740779. DOI: 10.3390/biomedicines11123109.
Therapeutic potential of Coptis chinensis for arthritis with underlying mechanisms.
Li M, Tian F, Guo J, Li X, Ma L, Jiang M Front Pharmacol. 2023; 14:1243820.
PMID: 37637408 PMC: 10450980. DOI: 10.3389/fphar.2023.1243820.
Singh V, Naldi A, Soliman S, Niarakis A NPJ Syst Biol Appl. 2023; 9(1):33.
PMID: 37454172 PMC: 10349856. DOI: 10.1038/s41540-023-00294-5.
Biomarkers (mRNAs and non-coding RNAs) for the diagnosis and prognosis of rheumatoid arthritis.
Jiang Y, Zhong S, He S, Weng J, Liu L, Ye Y Front Immunol. 2023; 14:1087925.
PMID: 36817438 PMC: 9929281. DOI: 10.3389/fimmu.2023.1087925.